Skip to main content

Your search for “antibody” returned 209 results

Three UC San Diego Professors Named Recipients of 2018 Breakthrough Prize

December 3, 2017

Two full-time University of California San Diego faculty members — Don Cleveland, who studies fundamental cellular mechanisms in the search for new treatments for diseases like amyotrophic lateral sclerosis (ALS), and James McKernan, a mathematician who investigates algebraic geometry and multivariate polynomials — are recipients of the 2018 Breakthrough Prize,…

Clearing the Course for Glycans in Development of Flu Drugs

November 19, 2020

…help to prevent large antibody molecules from binding to the enzyme. The researchers’ findings, published in Biophysical Journal, likely apply more generally—including to the SARS-CoV-2 virus that causes COVID-19. Amaro will soon be releasing new findings about her latest research on the virus’ spike protein. Zeroing in on glycans and…

Crop Cure

October 15, 2015

…a large-scale and generating antibodies that target transporter proteins. In addition, CROPS researchers will determine molecular structures of key plant membrane transporters and their natural variants, providing a new framework for understanding how transporters function and contribute to agriculturally important crop traits. “Food and health are interrelated,” said Chang. “By…

Seven UC San Diego Professors Named AAAS Fellows

November 27, 2018

Seven researchers at the University of California San Diego have been named Fellows of the American Association for the Advancement of Science (AAAS), the largest general science organization in the United States and publisher of the journal Science.

Cancer Isn’t Taking a Timeout for COVID-19; Neither are Clinical Trials

July 23, 2020

…uses a bispecific monoclonal antibody—an artificial protein that binds to two different types of antigen—to engage multiple T-cell targets simultaneously with the intent of making combination immunotherapies more effective. “UC San Diego Health stepped up and made sure I got the next best thing,” said Thurman. “It’s literally a matter…

Nanosponges Could Intercept Coronavirus Infection

June 17, 2020

Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.

Debashis Sahoo: From Computers to Cancer Genomes

September 23, 2016

Prof. Sahoo – whose journey into the world of cancer genomics was borne from his background in computer science – has been selected as a participating member of the Cancer Genomes and Networks program at UC San Diego Moores Cancer Center.

Startup Companies Tackle COVID-19 From Many Angles

April 16, 2020

…are focused on designing antibodies to prevent the virus from binding to a cell and then running simulations to determine their success. Others are tinkering with solutions to keep the coronavirus from replicating itself, in the event that it does infect a human cell. All of this represents potential movement…

Scientists Try Old Weapon Against Deadly New Target

October 23, 2014

…that unlike Zmapp, whose antibodies must be grown in a plant model, a time-consuming process, the manufacture of brincidofovir is comparatively quick and easily scaled up. Second, brincidofovir has been clinically tested on more than 1,000 human subjects, many of whom were desperately ill, and many of whom were children.…

Unprecedented Case Series Advances Promise of Phage Therapy

June 9, 2022

An international team of researchers, led by scientists at University of California San Diego School of Medicine and the University of Pittsburgh, report promising results from the largest case series yet of patients treated with bacteriophage therapy for antibiotic-resistant infections.

Category navigation with Social links